DocWire News Editors

DocwireNews

<h1 class="entry-title"><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/e-cigarettes-vaping-potential-cardiovascular-problems/">E-Cigarettes, Vaping are Associated With Heart Problems</a><p>&ldquo;In response to the harmful effects of tobacco smoking, the use of electronic cigarettes (e-cigarettes) has emerged and gained significant popularity over the past 15 years,&rdquo; the authors of this <a href="https://journals.sagepub.com/doi/full/10.1177/2047487320941993">position paper</a> published in the European Journal of Preventive Cardiology wrote. &ldquo;E-cigarettes are promoted as safe alternatives for traditional tobacco smoking and are often suggested as a way to reduce or quit smoking. However, evidence suggests they are not harmless.&rdquo;</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/e-cigarettes-vaping-potential-cardiovascular-problems/</p><p>&ndash;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/disparities-cardiac-death-count-level-differences/">Concern Over Growing Disparities in Premature Cardiac Deaths</a></h2><p>&ldquo;From the 1960s to 2010s, the United States experienced remarkable decline in cardiovascular disease mortality that was coined as one of the major public health accomplishments of the 20th century,&rdquo; said <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/disparities-cardiac-death-count-level-differences/">this study&rsquo;s</a> lead investigator Zhi-Jie Zheng, MD, PhD, a University Endowed Distinguished Professor and chair of the department of global health at Peking University in Beijing, China, in a press release. &ldquo;Increasing numbers of out-of-hospital deaths and fatal heart attacks in younger age groups, coupled with a steady widening of disparity of socioeconomic and health environment factors affecting health care at the county level, appear to be the key drivers of the slowdown we have seen since 2010.&rdquo;</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/disparities-cardiac-death-count-level-differences/</p><p>&ndash;</p><h2><a href="https://www.docwirenews.com/condition-center/family-history-of-afib-increased-risk-for-cardiovascular-events/">Family History of AFib and the Risk for Cardiovascular Events</a></h2><p>Researchers for this paper looked at the extent to which a family history of atrial fibrillation presented an increased risk for adverse cardiovascular events. According to the results, a family history of AFib was detected in 368 (21.4%) of patients in the study. Of those, 3.5% had two or more relatives affected by AFib, and the age of AFib decreased progressively in those without a history of AFib relative to those with single or multiple relatives affected (P&lt;0.001).</p><p>https://www.docwirenews.com/condition-center/family-history-of-afib-increased-risk-for-cardiovascular-events/</p><p>&ndash;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/high-deductible-health-plans-risk-for-cardiovascular-outcomes/">High-deductible Plans and Risk Not Linked with Risk</a></h2><p>Published in <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2768615"><em>JAMA Network Open</em></a>, this cohort study included more than 156,000 individuals with cardiovascular disease risk factors who were continuously enrolled in low-deductible ($500 or less) health plans who switched to a high-deductible plan due to employer mandate ($1,000 or more) for four years. According to the study results, first major adverse cardiovascular events in the high-deductible cohort did not have different outcomes relative to the matched controls at follow-up versus baseline (adjusted HR=1.00; 95% CI, 0.89 to 1.13). They also reported similar findings in the subgroups.</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/high-deductible-health-plans-risk-for-cardiovascular-outcomes/</p><p>&nbsp;</p><p>&nbsp;</p></h1>


Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Cardio Round-up: E-Cigarettes Harmful; Family History of AFib; and More

Cardiology

E-Cigarettes, Vaping are Associated With Heart Problems
 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe